FDA Flags Missing Trial Results - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

FDA Flags Missing Trial Results

Federal outreach seeks to improve compliance with ClinicalTrials.gov reporting requirements and make more complete clinical trial information publicly available

  • By

  • Kathryn Wighton

  • April 13, 2026

  • 3 min

Share

  • 1

    The FDA has reminded over 2,200 companies about the requirement to submit clinical trial results to ClinicalTrials.gov.

  • 2

    29.6% of studies likely subject to mandatory reporting had no results posted, contributing to publication bias.

  • 3

    The FDA's messages aimed to encourage voluntary compliance before considering further regulatory actions.

  • 4

    FDA Commissioner Marty Makary emphasized the ethical obligation to report all clinical trial results.

  • 5

    The initiative seeks to improve patient safety and inform clinicians about the benefits and risks of medical products.

Original Source(s)

FDA Flags Missing Trial Results

  • by Kathryn Wighton

  • April 13, 2026

Related Content

Top 10 Evidence-Based Essentials in Pathology

A structured framework of diagnostic classifications, reporting frameworks, staging systems, coding resources, and molecular pathology tools used in practice.

AI Tool Finds More Long COVID Cases Than Codes

Nearly 90% of patients who met algorithmic criteria for postacute sequelae of SARS-CoV-2 infection had at least 1 chronic or potentially chronic condition requiring ongoing clinical management.

Measles-Related Vitamin A Searches Rise

Google Trends data showed increased US search interest in vitamin A and cod liver oil during the 2025 measles outbreak, but normalized search data cannot determine actual product use, dosing behavior, or harms.